| Typicality: | 0.405 |
| Saliency: | 0.455 |
| as one of their pharmacodynamic effects | 4 | manner |
| further | 2 | manner |
| drug → cause → qt prolongation | 56 |
| drug → induce → qt prolongation | 10 |
| drug → be known to → prolong qt | 9 |
| drug → be associated with → qt prolongation | 7 |
| drug → demonstrated → qt prolongation | 5 |
| drug → prolong → the qt | 4 |
| negative | neutral | positive |
| 0.506 | 0.461 | 0.033 |
| Raw frequency | 91 |
| Normalized frequency | 0.455 |
| Modifier score | 0.650 |
| Perplexity | 21.483 |